Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

68.31
+0.20000.29%
Pre-market: 69.811.50+2.20%08:53 EST
Volume:816.04K
Turnover:55.75M
Market Cap:5.43B
PE:8.85
High:69.28
Open:67.86
Low:67.57
Close:68.11
52wk High:69.88
52wk Low:35.95
Shares:79.44M
Float Shares:65.01M
Volume Ratio:1.14
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.72
EPS(LYR):-4.7276
ROE:-7740.12%
ROA:23.81%
PB:-26.27
PE(LYR):-14.45

Loading ...

Dec 02, 2024

Major Issues Report

Form 8-K - Current report
Nov 27, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 18, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 18, 2024

Major Issues Report

Form 8-K - Current report
Aug 27, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Major Issues Report

Form 8-K - Current report
May 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 25, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 25, 2024

Major Issues Report

Form 8-K - Current report
Apr 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities